Huadong Medicine Co., Ltd (SHE:000963)
24.85
-0.54 (-2.13%)
Nov 20, 2026, 3:04 PM CST
Huadong Medicine Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Huadong Medicine stock has a consensus rating of "Buy" and an average price target of ¥36.09. The average 1-year stock price forecast is 45.23% higher than the current stock price, while the lowest is ¥27.10 (+9.05%) and the highest is ¥42.00 (+69.01%).
Price Target: ¥36.09 (+45.23%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Huadong Medicine stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 7 | 6 | 6 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 12 | 10 | 9 | 9 | 9 | 9 |
Financial Forecast
Revenue This Year
44.15B
from 43.61B
Increased by 1.23%
Revenue Next Year
44.99B
from 44.15B
Increased by 1.90%
EPS This Year
2.11
from 1.89
Increased by 11.82%
EPS Next Year
1.75
from 2.11
Decreased by -17.32%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.